MedTrace Logo

Adjuvant Acupuncture Care for Breast Cancer Patients Experiencing Side Effects From Chemotherapy

NCT00885183 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2019-07-01

No results posted yet for this study

Summary

Breast cancer patients report many symptoms while undergoing conventional care, including nausea/vomiting, fatigue, pain, depression and anxiety. Existing interventions to address these common side effects of treatment are limited. Patients diagnosed with cancer frequently seek complementary medicine (CAM), and there is a need to investigate potential effects of CAM therapies. This phased pilot and feasibility study has two aims:

1. Develop an acupuncture treatment protocol for adjuvant acupuncture care for breast cancer patients undergoing chemotherapy using structured interviews with established acupuncture teams in Norway.
2. Implement the treatment protocol in a pilot study to evaluate outcome measures, effect sizes and acceptability of acupuncture care delivered alongside conventional care.

Study results will support the design of future research; including a Phase III randomised controlled trial.

Conditions

Interventions

PROCEDURE

Acupuncture therapy

12 acupuncture treatment sessions for a period of 16 weeks

Sponsors & Collaborators

  • Norwegian Cancer Society

    collaborator OTHER

  • University Hospital of North Norway

    lead OTHER

Principal Investigators

  • Sameline Grimsgaard, MD, MPH, PhD · Clinical Research Centre, University Hospital of North Norway

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2013-12-31
Completion
2014-06-30

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00885183 on ClinicalTrials.gov